Navigation Links
Feasibility of Multiplexing Bio-Plex Total Target and Phosphoprotein Assays

Qian Gao, Joella Blas, and Efthalia Gerasimopoulos, Bio-Rad Laboratories, Inc., Hercules, CA 94547 USA


Introduction
Bio-Plex assays allow detection of mutiple target proteins in a small volume of sample. The assays are based on detection of signal from tagged fluorescent beads (xMAP technology) that have bound to each target protein. Typically, each type of bead is conjugated with distinct antibodies that recognize one of the target proteins. Appropriate sets of beads are then selected that enable simultaneous, or multiplex, assays of the proteins of interest in the sample. Bio-Plex phosphoprotein assays report the level of a protein that is phosphorylated at a specific site or sites, while total target assays report the level of the protein regardless of its phosphorylation state.

Typically, because of epitope binding competition for the same target protein, a total target assay should not be multiplexed with the corresponding phosphoprotein assay. Also, because the pair of antibodies used in the two assays differ, the signal from a total target assay may not be comparable to that of its corresponding phosphoprotein assay, so it is not appropriate to calculate the percentage of phosphorylated target protein using the results from a total and a phosphoprotein assay in the same reaction. However, because maximizing the number of assays in a particular reaction is desirable to conserve sample, in this note, we present results from a case study testing the feasibility of multiplexing a Bio-Plex total target assay with Bio-Plex phosphoprotein assays for different target proteins. This study was designed to answer two questions:

Can a total target assay be multip lexed with phosphoprotein assays?
Can a total target assay detect differences in protein concentration among samples?


Methods
We designed the study using HEK 293 cells, which respond to UV treatment by increasing the level of phosphorylation of several proteins. All proteins selected for the phosphoprotein assays in this study are activated by this treatment. The multiplex run (6-plex) included the following targets:

Total ERK2
Phospho-p53 (Ser15)
Phospho-p70 S6 kinase (Thr421/Ser424)
Phospho-ATF-2 (Thr71)
Phospho-JNK (Thr183/Tyr185)
Phospho-c-Jun (Ser63)

Untreated and UV-treated HEK 293 cell lysates were prepared according to methods detailed in the Bio-Plex phosphoprotein assay instruction manual. Both untreated HEK 293 and UVtreated HEK 293 cell lysates were tested at three different protein concentrations to test dose-response characteristics of the assays. Blank wells were included in the run, with cell lysis/assay buffer used to replace the cell lysate. Duplicates were run for each sample.


Results and Discussion
Total Target Assays Can Be Multiplexed With Phosphoprotein Assays for Distinct Targets
Data from a multiplex run of five phosphoprotein assays with a total ERK2 assay are presented in Figure 1. To show the results clearly, each phosphoprotein signal was plotted together with the total ERK2 assay signal. Although the phosphorylation levels found between UV-treated and untreated cell lysates varied, the total ERK2 signal level at the same protein concentration was very consistent bet ween treatments, indicating that none of the phosphoprotein assays interfered with the total target assay in this multiplex run.

For all tested phosphoprotein targets, the level of detected phosphorylation increased in HEK 293 cells in response to UV treatment, with the extent of increase depending on the phosphoprotein, as expected. The most dramatic signal increase was detected for phospho-c-Jun (Ser63) (Figure 1E).

At 0.6 g/ml protein, there was more than a 40-fold increase in phospho-c-Jun signal detected in UV-treated HEK 293 compared to untreated cell lysate. Notably higher levels of phosphorylation were also detected for phosphorylated p70 S6 kinase and phospho-ATF-2 assays in UV-treated cell lysates. The signals for untreated cell lysates were consistently low across all diluted samples. The low signals, around 60 70 MFI, in untreated cell lysates made the ratio of UV-treated to untreated as high as 76 at 12 g of total protein concentration. Lower phosphorylation levels were detected for phospho-p53 (Ser15) and phospho-JNK (Thr183/Tyr185), but the signal differences between untreated and UV-treated cell lysates were still significant at all tested protein concentrations.

Data from this 6-plex run (one total target assay multiplexed with five phosphoprotein assays) suggest that it is practical to mutiplex Bio-Plex total target assays with Bio-Plex phosphoprotein assays, provided that the targets are not the same.

Total ERK2 Assay Results Correlated With Protein Concentration
The total ERK2 assay showed consistent results in both untreated and UV-treated HEK 293 cell lysates. The signal for total ERK2, though not linear, showed a good dose-response over the range from 12 to 0.6 g/ml. The same was true for the phosphoproteins in each of the treated samples. These results emphasize the importance of establishing the dose-response relationship between the concentration of each protein target and the corresponding signal when a specific cell lysate sample is tested. These results demonstrate that multiplexing a total assay with five phosphoprotein assays can detect differences among samples with different protein concentrations.


Conclusions
The results of this study successfully answered the questions posed, demonstrating that:
A total target assay can be multiplexed with phosphoprotein assays, provided the target proteins are different
A total target assay can detect differences in protein concentrations among samples

xMAP is a trademark of Luminex Corporation. The Bio-Plex suspension array system includes fluorescently labeled microspheres and instrumentation licensed to Bio-Rad Laboratories, Inc. by the Luminex Corporation.

Information in this tech note was current as of the date of writing (2005) and not necessarily the date this version (Rev A, 2005) was published.


back to top
'"/>

Source:


Page: All 1 2 3 4

Related biology technology :

1. Bio-Plex Cytokine Immunoassays and ELISA: Comparison of Two Methodologies in Testing Samples From Asthmatic and Healthy Children, Rev A
2. Detection of Phosphorylated and Total ERK and p38 MAPK by Bio-Plex Assay, ELISA, and Western Blotting, Rev A
3. Correlation of Bio-Plex Suspension Array Reader Validation With Multiplex Cytokine Assay Performance, Rev A
4. Selection of Standards for Bio-Plex Cytokine Assays, Rev A
5. Application of the Bio-Plex Cell Lysis Kit in Western Blot Analysis of Phosphoproteins, Rev A
6. Development of a Multiplex Bead-Based Assay for Antibody Screening of a Nonhuman Primate Colony on the Bio-Plex System
7. New Kit Generates Exceptionally Pure Total RNA for RT-PCR
8. High-Throughput Isolation of Total RNA
9. Isolate and Analyze Total RNA from Cells Harvested by Laser Capture Microdissection
10. Fast Isolation of Total RNA from Small Numbers of Cells
11. Total RNA Isolation Protocol 1,2,3
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/11/2017)... and LAGUNA HILLS, Calif. , Oct. 11, ... Research, London (ICR) and University of ... SkylineDx,s prognostic tool to risk-stratify patients with multiple myeloma (MM), ... nine . The University of Leeds ... funded by Myeloma UK, and ICR will perform the testing ...
(Date:10/11/2017)... ... October 11, 2017 , ... A new study ... in frozen and fresh in vitro fertilization (IVF) transfer cycles. The ... IVF success. , After comparing the results from the fresh and frozen transfer ...
(Date:10/10/2017)... ... October 10, 2017 , ... San Diego-based team building and ... rebranding initiative announced today. The bold new look is part of a transformation ... moves into a significant growth period. , It will also expand its service offering ...
(Date:10/10/2017)... PA (PRWEB) , ... October 10, 2017 , ... ... City Science Center’s FirstHand program has won a US2020 STEM Mentoring Award. Representatives ... the award for Excellence in Volunteer Experience from US2020. , US2020’s mission is ...
Breaking Biology Technology:
(Date:4/4/2017)... 2017   EyeLock LLC , a leader of ... States Patent and Trademark Office (USPTO) has issued U.S. ... of an iris image with a face image acquired ... company,s 45 th issued patent. ... given the multi-modal biometric capabilities that have recently come ...
(Date:3/30/2017)... , March 30, 2017 Trends, opportunities ... (physiological and behavioral), by technology (fingerprint, AFIS, iris recognition, ... recognition, and others), by end use industry (government and ... immigration, financial and banking, and others), and by region ... , Asia Pacific , and ...
(Date:3/24/2017)... Controller General of Immigration from Maldives Mr. Mohamed Anwar and ... international IAIR Award for the most innovative high security ePassport and eGates  ... ... Maldives Immigration Controller General, Mr. Mohamed Anwar ... right) have received the IAIR award for the "Most innovative high security ...
Breaking Biology News(10 mins):